Company Overview

Update
Headquarters:
San Francisco, CA
Funding:
$46.1M
Categories:
Biotechnology
Description:
Jennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.

Detailed Description

Update

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company’s lead product JX-594, currently in an international Phase 2 trial for primary liver cancer and colorectal cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse array of common cancers.

Current Team (8)

Update

Past Team (2)

Update

Funding Rounds (5) - $46.1M

Update

Board Members and Advisors (5)

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    201 Mission Street

    Suite 1380

    San Francisco, CA 94105

    USA

Images (1)

Update
  • 5b5dad2d9b4e44022c24a290c3fb4100